PR Newswire
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
📈
AI Sentiment
Highly Positive
8/10
- Home
- LNAI
LNAI
Lunai Bioworks Inc.
as of 12-12-2025 3:16pm EST
$1.10
$0.05
-4.24%
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
Chart Type:
Time Range:
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SUITE 906 LOS ANGELES |
| Market Cap: | 23.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.81 - $20.40 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lunai Bioworks Inc. News
LNAI Breaking Stock News: Dive into LNAI Ticker-Specific Updates for Smart Investing
Compare LNAI vs Leading Stocks
See how LNAI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LNAI Lunai Bioworks Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.